Dr. Carolina Reis Oliveira and Dr. Alessandra Zonari, co-founders of OneSkin, discuss how they are using recent advances in longevity science to create peptides that target senescent cells and inflammation in aged skin. They explain their rigorous discovery process, testing lead peptide OS-1 in 3D skin models and human trials, and validating safety and efficacy to meet regulatory requirements. They also share insights into launching a science-backed skincare brand and ongoing R&D for new applications.

Dr. Alessandra Zonari, a PhD in stem cell biology and co-founder of OneSkin, shares groundbreaking insights on skin aging. She explains how inflammation and diet affect our skin, debunks harmful skincare routines, and reveals the science behind peptides that can reverse skin's biological age. The conversation also highlights the crucial link between skin health and overall wellness, emphasizing the detrimental effects of UV exposure and sugars. With innovative approaches, Alessandra empowers listeners to rejuvenate their skin naturally.

Dr. Alessandra Zonari, Chief Scientific Officer of OneSkin, dives into the fascinating world of skin regeneration. She discusses the critical role of collagen in youthful skin and the impact of "zombie cells" on skin health. Dr. Zonari highlights the innovative OSO-1 peptide that targets these senescent cells to boost collagen production. She emphasizes a holistic approach to skincare, including lifestyle factors, and shares intriguing insights on the biological age of skin around the eyes. Get ready for groundbreaking insights into revitalizing your skincare regimen!